Jefferies Upgrades Eli Lilly to Buy, Announces $615 Price Target
Portfolio Pulse from richadhand@benzinga.com
Jefferies analyst Akash Tewari has upgraded Eli Lilly (NYSE:LLY) from Hold to Buy and announced a price target of $615.
August 09, 2023 | 8:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly's stock has been upgraded to Buy from Hold by Jefferies analyst Akash Tewari, with a new price target of $615.
The upgrade from Hold to Buy by Jefferies analyst Akash Tewari indicates a positive outlook for Eli Lilly's stock. The new price target of $615 suggests a significant potential upside, which could drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100